3rd Annual Advances in Immuno-Oncology Congress

  • Check with publisher
  • Published date: December 19, 2017
    • London, United Kingdom

Following on from its huge success in 2017, Oxford Global are proud to present their 3rd Annual Advances in Immuno-Oncology Congress, 24-25 May, London, UK. This event will host over 300 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies.
The worlds most leading authorities will give over 50 presentations across 6 interactive streams, including;
• Discovery of Immuno-Oncology Therapies
• Translational Immuno-Oncology
• Genomics in Cancer Immunotherapy and Precision Medicine
• Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology
• Immuno-Oncology Therapeutics Approaches: Clinical Research and Clinical Trials
• Microbiome in Immuno-Oncology

Free Pre-Congress Live Webinars

Novel Checkpoint Inhibitors & Strategies for Combined Modality Treatment
Hosted by Geert Mudde, Founder and Chief Scientific Officer, TYG Oncology Ltd.
Register Here: http://bit.ly/2BeBVBc

Personalised Medicine and Immuno-Oncology
Hosted by Agnete Fredriksen, Chief Scientific Officer, Vaccibody.
Register Here: http://bit.ly/2AZUJzU

For further information, prices & discounts please contact a.fernandez@oxfordglobal.co.uk or click here: http://bit.ly/2oJlVB7
Alternatively visit our website http://bit.ly/2kiJtbg

Result 0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Head and Neck Cancers

    Head and Neck Cancers

    Life Sciences Shirley (New York) December 26, 2018 Check with publisher

    Creative Biolabs is a world leader in the field of cancer vaccine development. With our extensive experience and advanced platform, we are therefore confident in offering the best vaccine development services for different types of head and neck canc...

  • ZCCHC11/PAPD3  peptide

    ZCCHC11/PAPD3 peptide

    Life Sciences Shirley (New York) December 21, 2018 Check with publisher

    ZCCHC11 is an RNA uridyltransferase (EC 2.7.7.52) that uses UTP to add uridines to the 3-prime end of substrate RNA molecules (Jones et al., 2009 (PubMed 19701194)).(supplied by OMIM, Jan 2011). https://www.creative-diagnostics.com/ZCCHC11-PAPD3-pept...

  • WNT15/WNT9B  peptide

    WNT15/WNT9B peptide

    Life Sciences Shirley (New York) December 21, 2018 Check with publisher

    The WNT gene family consists of structurally related genes that encode secreted signaling proteins. These proteins have been implicated in oncogenesis and in several developmental processes, including regulation of cell fate and patterning during emb...